ArticleDermatology reports2025
Optimizing targeted therapy for metastatic melanoma: a combination of encorafenib and trametinib beyond standard protocols.
François Pélouard et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it